László Őrfi Selected Research

László Őrfi Research Topics

7	Neoplasms (Cancer) 01/2023 - 11/2013
1	Fibrosis (Cirrhosis) 12/2023
1	Inflammation (Inflammations) 12/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Hyperalgesia 11/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019
1	Leukemia 01/2018
1	Melanoma (Melanoma, Malignant) 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Insulin Resistance 01/2016
1	Obesity 01/2016

4	Phosphotransferases (Kinase)IBA 12/2019 - 01/2014
2	PyrazinesIBA 01/2016 - 11/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014 - 11/2013
1	CollagenIBA 12/2023
1	Protein Kinase InhibitorsIBA 01/2023
1	p38 Mitogen-Activated Protein KinasesIBA 01/2023
1	TetralonesIBA 12/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 11/2020
1	tyrosine receptor (receptor, tyrosine)IBA 12/2019
1	EstersIBA 01/2018
1	pyridineIBA 01/2016
1	Insulin Receptor Substrate ProteinsIBA 01/2016
1	Nonesterified Fatty Acids (NEFA)IBA 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016
1	Serine (L-Serine)FDA Link 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 11/2013